Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer6 Nov 2026

257 Preclinical evaluation of in vivo CAR-T therapies using human PBMC and HSC reconstituted mouse models in Biocytogen

Qiang Liu¹
Xuan Yu²
Jay Zhang³
Zhiyuan Shen⁴
Zhongxiao Cong¹

4 affiliations

¹Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China
²Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China
³Biocytogen Pharmaceuticals, Beijing, China
⁴1Biocytogen Pharmaceuticals, Beijing, China

Open at source PDF DOI Cite

From preclinical promise to regulatory reality: translation of small rodent acute injury therapies to human approval and safety outcomes: A systematic review
Timothy R. Entwistle, William R. Cowey, Eliza Stokoe +2
PLOS One28 Sep 2026Peer-reviewedCC BY 4.0Full textClinical trials & evidence synthesis Epidemiology & public healthPLOS
Preclinical and Pilot Human Evaluation of [18F]NIDF-1, an N-Protonation-Guided Tau PET Tracer
Wantong Guo, Yishuo Wang, Yuying Li +7
ChemRxiv20 Sep 2026PreprintCC BYFull textPhysiologyChemRxiv
618 A novel preclinical mouse model to investigate IL-18-targeting therapies
Gaëlle Martin, Fabiane Sônego, Patricia Isnard-Petit +2
Journal for ImmunoTherapy of Cancer4 Nov 2026Peer-reviewedCC BYImmunology OncologyDOAJ
The global preclinical research and development landscape for pre-eclampsia and eclampsia therapies
Jessica Postregna, Kate Mills, Fiona Bruinsma +8
Communications Medicine14 Jul 2026Peer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsPMC
Preclinical Evaluation of Bacterial Lysates in Murine Disease Models: A Systematic Review
Diana‐Larisa Ancuța, Cristin Coman
Immunity, inflammation and disease1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX RIS

BibTeX

@article{liu2026preclinical,
  title = {{257 Preclinical evaluation of in vivo CAR-T therapies using human PBMC and HSC reconstituted mouse models in Biocytogen}},
  author = {Qiang Liu and Xuan Yu and Jay Zhang and Zhiyuan Shen and Zhongxiao Cong},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0257},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0257},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - 257 Preclinical evaluation of in vivo CAR-T therapies using human PBMC and HSC reconstituted mouse models in Biocytogen
AU  - Qiang Liu
AU  - Xuan Yu
AU  - Jay Zhang
AU  - Zhiyuan Shen
AU  - Zhongxiao Cong
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0257
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0257
SN  - 2051-1426
ER  -

Related

Cite